Equities research analysts forecast that UnitedHealth Group Inc (NYSE:UNH) will announce $50.02 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have made estimates for UnitedHealth Group’s earnings, with the highest sales estimate coming in at $50.61 billion and the lowest estimate coming in at $48.97 billion. UnitedHealth Group posted sales of $46.49 billion in the same quarter last year, which suggests a positive year-over-year growth rate of 7.6%. The business is expected to announce its next quarterly earnings results on Tuesday, July 18th.

According to Zacks, analysts expect that UnitedHealth Group will report full year sales of $50.02 billion for the current financial year, with estimates ranging from $199.75 billion to $201.13 billion. For the next financial year, analysts expect that the firm will report sales of $216.93 billion per share, with estimates ranging from $211.41 billion to $220.8 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.17 by $0.20. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. The firm had revenue of $48.72 billion during the quarter, compared to analyst estimates of $48.21 billion. During the same period last year, the company earned $1.81 EPS. UnitedHealth Group’s quarterly revenue was up 9.4% compared to the same quarter last year.

Several research analysts recently weighed in on the company. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $193.00 price objective for the company in a research report on Monday. Jefferies Group LLC reiterated a “buy” rating and issued a $192.00 price objective on shares of UnitedHealth Group in a research report on Friday, May 19th. Vetr lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $179.00 price target for the company. in a research report on Monday. Oppenheimer Holdings Inc. restated an “outperform” rating and set a $187.00 price target (up from $186.00) on shares of UnitedHealth Group in a research report on Friday, April 21st. Finally, Deutsche Bank AG restated a “buy” rating and set a $187.00 price target (up from $183.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Two equities research analysts have rated the stock with a hold rating and twenty-two have assigned a buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $182.78.

Shares of UnitedHealth Group (NYSE:UNH) traded down 0.33% during midday trading on Friday, hitting $177.46. The company had a trading volume of 1,262,895 shares. UnitedHealth Group has a 12 month low of $132.39 and a 12 month high of $178.89. The company has a market capitalization of $171.01 billion, a PE ratio of 22.72 and a beta of 0.68. The company has a 50-day moving average of $171.51 and a 200-day moving average of $163.62.

In other UnitedHealth Group news, EVP D Ellen Wilson sold 14,000 shares of the firm’s stock in a transaction on Wednesday, April 19th. The stock was sold at an average price of $170.54, for a total value of $2,387,560.00. Following the sale, the executive vice president now directly owns 31,993 shares in the company, valued at $5,456,086.22. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction on Thursday, April 20th. The shares were sold at an average price of $170.47, for a total value of $852,350.00. Following the completion of the sale, the director now owns 75,735 shares in the company, valued at $12,910,545.45. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 34,838 shares of company stock worth $5,944,983. 1.65% of the stock is owned by insiders.

A number of hedge funds have recently bought and sold shares of the stock. HM Payson & Co. boosted its stake in UnitedHealth Group by 6.3% in the first quarter. HM Payson & Co. now owns 2,778 shares of the healthcare conglomerate’s stock worth $456,000 after buying an additional 165 shares in the last quarter. Proficio Capital Partners LLC boosted its stake in UnitedHealth Group by 125.4% in the first quarter. Proficio Capital Partners LLC now owns 1,251 shares of the healthcare conglomerate’s stock worth $220,000 after buying an additional 696 shares in the last quarter. Public Employees Retirement System of Ohio boosted its stake in UnitedHealth Group by 12.5% in the first quarter. Public Employees Retirement System of Ohio now owns 755,380 shares of the healthcare conglomerate’s stock worth $123,890,000 after buying an additional 83,842 shares in the last quarter. Stonebridge Capital Advisors LLC boosted its stake in UnitedHealth Group by 142.3% in the first quarter. Stonebridge Capital Advisors LLC now owns 5,840 shares of the healthcare conglomerate’s stock worth $958,000 after buying an additional 3,430 shares in the last quarter. Finally, CCM Investment Advisers LLC boosted its stake in UnitedHealth Group by 1.1% in the first quarter. CCM Investment Advisers LLC now owns 52,432 shares of the healthcare conglomerate’s stock worth $8,599,000 after buying an additional 578 shares in the last quarter. Institutional investors own 86.67% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Zacks: Brokerages Anticipate UnitedHealth Group Inc (UNH) Will Post Quarterly Sales of $50.02 Billion” was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://www.americanbankingnews.com/2017/05/26/zacks-brokerages-anticipate-unitedhealth-group-inc-unh-will-post-quarterly-sales-of-50-02-billion.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

12 Month Chart for NYSE:UNH

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.